[go: up one dir, main page]

MA52337A - Nouveaux analogues d'oxaborole et utilisations de ces derniers - Google Patents

Nouveaux analogues d'oxaborole et utilisations de ces derniers

Info

Publication number
MA52337A
MA52337A MA052337A MA52337A MA52337A MA 52337 A MA52337 A MA 52337A MA 052337 A MA052337 A MA 052337A MA 52337 A MA52337 A MA 52337A MA 52337 A MA52337 A MA 52337A
Authority
MA
Morocco
Prior art keywords
oxaborole
analogues
latest
new
oxaborole analogues
Prior art date
Application number
MA052337A
Other languages
English (en)
Inventor
Paul Alan Glossop
Robert Toms Jacobs
Delphine Françoise Monique Launay
Yang Liu
Charles Eric Mowbray
Stephen John Robinson
Richard J Sciotti
Jason D Speake
Gavin Alistair Whitlock
Original Assignee
Anacor Pharmaceuticals Inc
Us Gov Sec Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc, Us Gov Sec Army filed Critical Anacor Pharmaceuticals Inc
Publication of MA52337A publication Critical patent/MA52337A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA052337A 2017-03-01 2018-03-01 Nouveaux analogues d'oxaborole et utilisations de ces derniers MA52337A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762465294P 2017-03-01 2017-03-01

Publications (1)

Publication Number Publication Date
MA52337A true MA52337A (fr) 2021-03-03

Family

ID=63370509

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052337A MA52337A (fr) 2017-03-01 2018-03-01 Nouveaux analogues d'oxaborole et utilisations de ces derniers

Country Status (4)

Country Link
US (2) US10961261B2 (fr)
EP (1) EP3609504A4 (fr)
MA (1) MA52337A (fr)
WO (1) WO2018160845A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
WO2018160845A1 (fr) 2017-03-01 2018-09-07 Anacor Pharmaceuticals, Inc. Nouveaux analogues d'oxaborole et utilisations de ces derniers
EP4204012A1 (fr) 2020-08-31 2023-07-05 Pfizer Inc. Procédés de protection de l'arn
TWI870837B (zh) 2022-04-28 2025-01-21 日商日本農藥股份有限公司 具肟基之含氮雜環化合物及含有該化合物之農園藝用除草劑、以及彼等之使用方法
WO2024177602A1 (fr) * 2023-02-20 2024-08-29 Yeditepe Universitesi Utilisation du bore pour le traitement de la leishmaniose d'origine neuronale

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2509645A1 (fr) 2002-12-18 2004-07-08 Anacor Pharmaceuticals, Inc. Antibiotiques contenant des complexes d'acide borinique et leurs procedes d'utilisation
MXPA05013848A (es) 2003-06-16 2006-09-04 Anacor Pharmaceuticals Inc Agentes terapeuticos que contienen boro hidroliticamente resistentes y metodos de uso.
AR049915A1 (es) 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Compuestos con contenido de boro y metodos de uso de los mismos
US7393856B2 (en) 2004-06-14 2008-07-01 Anacor Pharmaceuticals, Inc. Anti-viral uses of borinic acid complexes
DK2719388T3 (da) 2006-02-16 2019-05-13 Anacor Pharmaceuticals Inc Borholdige små molekyler som antiinflammatoriske midler
EP2015757A4 (fr) 2006-05-02 2011-01-26 Anacor Pharmaceuticals Inc Substances thérapeutiques contenant du bore résistant à l'hydrolyse et méthodes d'utilisation
EP2044091A4 (fr) 2006-06-12 2010-08-04 Anacor Pharmaceuticals Inc Composés destinés au traitement d'une maladie périodontale
JO3396B1 (ar) 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
WO2009111676A2 (fr) 2008-03-06 2009-09-11 Anacor Pharmaceuticals, Inc Petites molécules contenant du bore utilisées en tant qu'agents anti-inflammatoires
JP2011515359A (ja) * 2008-03-18 2011-05-19 グラクソ グループ リミテッド 治療用トリアゾールアミド誘導体
EP2285384A4 (fr) 2008-05-12 2012-04-25 Anacor Pharmaceuticals Inc Petites molécules contenant du bore
EP2348863A4 (fr) 2008-09-04 2012-03-07 Anacor Pharmaceuticals Inc Petites molécules contenant du bore
US9493489B2 (en) 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
WO2010045505A1 (fr) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc Petites molécules contenant du bore en tant qu’agents antiprotozoaires
PE20120052A1 (es) 2008-12-17 2012-02-13 Anacor Pharmaceuticals Inc Polimorfos de (s)-3-amino-metil-7-(3-hidroxi-propoxi)-3h-benzo-[c][1,2]-oxaborol-1-ol
JP2013500974A (ja) 2009-07-28 2013-01-10 アナコール ファーマシューティカルズ,インコーポレイテッド 三置換ホウ素含有分子
US9440994B2 (en) * 2009-08-14 2016-09-13 Anacor Pharmaceuticals, Inc. Boron containing small molecules as antiprotozoal agents
US20110207701A1 (en) 2009-08-19 2011-08-25 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US20110124597A1 (en) 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
US9346834B2 (en) 2009-10-20 2016-05-24 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US8461134B2 (en) 2009-11-11 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011094450A1 (fr) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Petites molecules contenant du bore
WO2011116348A1 (fr) 2010-03-19 2011-09-22 Anacor Pharmaceuticals, Inc. Petites molécules borées en tant qu'agent anti-protozoaire
HUE059033T2 (hu) 2010-09-07 2022-10-28 Anacor Pharmaceuticals Inc Benzoxaborol-származékok bakteriális fertõzések kezelésére
WO2012145734A1 (fr) * 2011-04-22 2012-10-26 The Ohio State University Compositions antileshmaniennes et ses méthodes d'utilisation
AR088669A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos
AR088668A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Moleculas pequeñas que contienen boro
JP6298472B2 (ja) * 2012-11-19 2018-03-20 ノバルティス アーゲー 寄生虫病の処置のための化合物および組成物
US9598443B2 (en) * 2013-02-01 2017-03-21 Anacor Pharmaceuticals, Inc. Boron containing small molecules as antiprotozoal agents
WO2015013318A1 (fr) 2013-07-22 2015-01-29 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore
WO2018160845A1 (fr) 2017-03-01 2018-09-07 Anacor Pharmaceuticals, Inc. Nouveaux analogues d'oxaborole et utilisations de ces derniers

Also Published As

Publication number Publication date
WO2018160845A1 (fr) 2018-09-07
US20200024289A1 (en) 2020-01-23
EP3609504A4 (fr) 2021-03-03
US10961261B2 (en) 2021-03-30
US20210253605A1 (en) 2021-08-19
EP3609504A1 (fr) 2020-02-19
US11691992B2 (en) 2023-07-04

Similar Documents

Publication Publication Date Title
MA52337A (fr) Nouveaux analogues d'oxaborole et utilisations de ces derniers
MA51288A (fr) Analogues d'incrétine et leurs utilisations
MA46180A (fr) Analogues de l'amyline
MA51287A (fr) Analogues d'incrétine et leurs utilisations
EP3595694A4 (fr) Construction de furtif immunitaire cas9 crispr
IL268891A (en) Polyploid adeno-associated virus vectors and methods of making and using the same
MA46589A (fr) Composés et utilisations de ces derniers
EP3411411A4 (fr) Composés benzopyrazole et analogues de ceux-ci
MA49847A (fr) Production enzymatique d'hexoses
EP3615019A4 (fr) Modulateurs de l'interaction sestrine-gator2 et utilisations de ces derniers
EP3368663A4 (fr) Lignées cellulaires exemptes de virus et procédés d'obtention de celles-ci
EP3925950C0 (fr) Synthèse d'omecamtiv mecarbil
MA47494A (fr) Nouvelles utilisations d'anticorps anti-sirpg
EP4057950A4 (fr) Exosquelette de membre inférieur
EP3347334A4 (fr) Déshydrohalogénation d'hydrochlorofluorocarbones
EP3436434A4 (fr) Analogues d'indoline et leurs utilisations
EP3585903A4 (fr) Production de caroténoïdes et d'apocaroténoïdes
EP3324894A4 (fr) Prothèse du genou à pivotement latéral et médian
EP3303366A4 (fr) Dérivés de dolastatine 10 et utilisations de ceux-ci
EP3506254A4 (fr) Structure d'insonorisation
EP3695672C0 (fr) Détermination d'un schéma de transmission
MA50872A (fr) Bouée et procédé d'installation de la bouée
EP3407974A4 (fr) Analogues d'amlexanox
IL268905B (en) Phage therapy
EP3519976A4 (fr) Gestion logicielle d'erreurs matérielles